Aurora Cannabis Inc (ACB)

[Reverand]

Message from Aurora Relations.

Thank you for your feedback and once again, we appreciate you sharing your frustrations with us. With our increased availability of supply and global footprint in 25 countries, Aurora is tracking towards positive EBITDA and the shift to a strong cash flow position. We are maximizing out average selling price through – leadership in key international markets with new higher margin medical products, full margin capture in EU and Latin America with direct distribution channels and commitment to scientific research and product development, resulting in new higher margin products for the second phase of legalization in Canada.

With Sky class facilities coming online, we are also driving down the cash costs per gram through world class automation, genetics, research and large-scale pharmaceutical grade production.

With that said, as we mentioned before, Aurora is focused on creating value and executing our strategic near and long term business goals. And there are several factors affecting the stock price of the market, including international economic and political news and it is not entirely controlled by Aurora.



We recommend every investor to seek advise from an investment advisor to understand market risks and make informed investment decisions. The investor relations team cannot make any recommendations on your portfolio.



Best,